Medtronic plc (MDT) : The total money flow in Medtronic plc (MDT) was negative ($33.17 million), which signals selling by the traders on Mondays session. They trimmed their holdings by selling the stock on downticks to the tune of $74.06 million. In comparison, the inflow of money into the stock on upticks was $40.89 million. The uptick to downtick ratio was 0.55. Similarly, the block trades show selling by large traders on strength. The value of stocks sold down on downtick was $43.54 million. The value of transactions on uptick was $0.89 million. The negative money flow of ($42.65 million) confirms the selling in Medtronic plc (MDT) on strength. The uptick to downtick ratio of block trades was 0.02. Medtronic plc (MDT) gained $0.37 at $87.91, a gain of 0.42% over the previous days close. However, the stock registered 0.94% in the week.
Shares of Medtronic plc appreciated by 1.09% during the last five trading days but lost 0.51% on a 4-week basis. Medtronic plc is up 7.88% in the last 3-month period. Year-to-Date the stock performance stands at 15.44%.
Medtronic plc (NYSE:MDT): During Mondays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $87.43 and $87.18 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $88.17. The buying momentum continued till the end and the stock did not give up its gains. It closed at $87.91, notching a gain of 0.42% for the day. The total traded volume was 3,164,903 . The stock had closed at $87.54 on the previous day.
In a related news, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the officer (EVP, President, MITG) of Medtronic Plc, Hanson Bryan C had sold 15,000 shares worth of $1,305,000 in a transaction dated July 26, 2016. In this transaction, 15,000 shares were sold at $87 per share.
Medtronic plc (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. Medtronic, Inc. is a subsidiary of the Company.